Beef Prices: Blame the Packers, Not America’s Ranchers
KEY POINTS Beef prices are at record highs—not because of U.S. ranchers or tariffs, but because dependence on foreign imports and meatpacker consolidation have distorted
Senate Witnesses Discuss Reshoring and Making China’s Massive Biotech Ecosystem Less Attractive for Big Pharma
Witnesses at a Senate hearing on Wednesday, Oct. 29 titled “The Future of Biotech” discussed ways to facilitate reshoring and making it attractive to expand in the U.S. and conduct R&D here instead of in China.
With China Agreement Complete, CPA Urges Trump Administration to Prioritize 232 Investigations and Domestic Producers
President Trump has already made the most important deal of his life—his promise to the American people to end U.S. dependence on China and rebuild our domestic industrial capacity.
At Senate Commerce, Bipartisan Support for Shipbuilding Industry. So What is Congress Waiting For?
There are very few things that Democrats and Republicans agree on. One of them is the need to support domestic shipbuilding beyond just military vessels.
CPA Releases New Economics Report on America’s Chip-for-Chip Tariff Policy
The report, titled “America’s Chip-for-Chip Tariff Policy: The Urgent Fight to Reclaim Industrial Independence Before It’s Too Late,” finds that the United States now produces only 10 percent of the world’s chips—and almost none of the most advanced ones—while China has captured the majority of global capacity for legacy chips, the mature semiconductors essential to cars, medical devices, and industrial equipment.
No, America is Not Too Economically Successful to Need Reform
On the surface, America looks like an unrivaled success story. Yet beneath the headline numbers lies an economy increasingly dependent on foreign production, hollowed out in critical industries, and unable to provide secure, high-wage work for many of its citizens.
To Reshore Generic Drugs, Use Sugar’s Sweet Model
America is finally getting serious about its dangerous dependence on foreign-made generic drugs.
CPA Submits Section 232 Comments on Imports of Personal Protective Equipment, Medical Consumables, and Medical Equipment, Including Devices
The Trump administration’s section 232 investigation into medical devices and personal protective equipment is a vital step toward ensuring America takes back control over its production and domestic supply of critical medical products.
ICYMI: CPA Economist Andrew Rechenberg Stars at Hearing on Fixing America’s Broken Drug Supply Chain
The hearing continued the committee’s efforts to examine and reduce America’s severely dangerous over-dependence on foreign-manufactured generic drugs and address vulnerabilities in the nation’s pharmaceutical supply chain.
CPA Applauds President Trump for Imposing Tariffs on Medium and Heavy-Duty Imported Trucks
Move seen as a critical step to protect U.S. manufacturing, American jobs, and national security WASHINGTON, D.C. — The Coalition for a Prosperous America (CPA)
